Aortic Aneurysm Management

Diagnosis and Monitoring

The European Society of Cardiology recommends using CT angiography or MRI for baseline measurements, and TTE can be used for initial assessment, but has limitations in visualizing the entire ascending aorta 1
TTE may underestimate aortic dimensions by 1-2 mm, therefore, confirm measurements with CT or MRI 2
The same imaging modality and facility should be used for consistency in measurements, and MRI is preferred over CT for long-term surveillance to minimize radiation exposure 1
Patients with aortic diameters ≥4.0 cm require more frequent surveillance, and monitoring for growth rate becomes crucial at an aneurysm size of 4.0 cm, as growth ≥3 mm/year is considered a high-risk feature 1

Presence of bicuspid aortic valve, COPD, and family history of aortic dissection are significant risk factors that require assessment 1, 2

Mean growth rate for ascending aortic aneurysms is 0.9 mm per year (95% CI: 0.6 to 1.2), and some patients may experience faster growth of up to 2 mm per year 2
Growth ≥3 mm/year is considered a high-risk feature requiring closer monitoring 1
The American College of Cardiology recommends CT or MRI imaging at 12-month intervals for isolated aortic arch aneurysms less than 4.0 cm in diameter, and at 6-month intervals for aneurysms 4.0 cm or greater 3

Consider referral to a vascular specialist if growth rate exceeds 3 mm/year, aneurysm reaches 4.5 cm in diameter, or patient develops symptoms (chest pain, aortic regurgitation) 1
Current guidelines recommend surgical intervention when the ascending aortic aneurysm reaches 5.5 cm in diameter, and intervention is generally not indicated until aortic arch aneurysms reach 5.5 cm in diameter in low-risk patients 1, 2, 3
For high-risk features (rapid growth, symptoms, or specific patient factors), lower thresholds may apply, and rapid expansion (>10 mm/year) and development of symptoms are indications for intervention 1, 3

Aggressive management of hypertension is essential in patients with any aortic aneurysm, as emphasized by the European Heart Journal 1
Avoiding fluoroquinolones is recommended, as these antibiotics increase the risk of complications in patients with aortic aneurysms, according to the European Heart Journal 4

Relying solely on TTE for follow-up is not recommended for surveillance of aneurysms in the distal ascending aorta or aortic arch, and inconsistent imaging techniques can lead to measurement discrepancies 1
Neglecting to assess the entire aorta and overlooking aortic valve assessment, particularly for bicuspid aortic valve, are significant mistakes 1
Failing to track aneurysm size progression over time and paying particular attention to growth rate (growth ≥3 mm per year) is crucial, as indicated by the European Heart Journal 1
Failing to assess for any development of symptoms (hoarseness, dysphagia, dyspnea, chest or back pain) is essential, according to the American College of Cardiology 3